Population studies are very good at revealing risk. They can show how common hypertension is, how cardiovascular risk differs between communities, and how diet, obesity, diabetes, environment and socioeconomic conditions cluster. The harder question begins after risk has been identified: does the health system convert detection into durable control?
Long-running population cohorts such as PURE have quantified modifiable risks across diverse countries and shown that the importance of particular exposures varies by setting. Implementation programmes such as STOP-NCDs ask a different question: how can evidence-based hypertension and diabetes care actually be delivered and sustained, including nurse-led care, digital support, medication access and health-system financing? Regional reviews of rural African hypertension interventions reinforce the gap between detection and control. Decentralized and nurse-led approaches are promising, but many interventions cover only parts of the care cascade and report programme theory, fidelity or sustainment inconsistently.
The most useful next step is therefore not another prevalence estimate in isolation. It is identifying where people leave the chronic-care pathway and which combinations of workforce design, financing, medicines, digital support and longitudinal follow-up keep them connected.
Publications behind this Insight
What Changes When Cardiovascular Risk Is Studied Across 21 Countries?
What Changes When Cardiovascular Risk Is Studied Across 21 Countries?. 2020. 10.1016/S0140-6736(19)32008-2.
Open publicationEvidence behind this Insight
- 1. Yusuf S, et al. Modifiable risk factors and cardiovascular outcomes across 21 countries. Lancet. 2020. DOI 10.1016/S0140-6736(19)32008-2. What Changes When Cardiovascular Risk Is Studied Across 21 Countries?
- 2. STOP-NCDs CIHR funding record. WEMA Project
- 3. Peniston S, et al. Rural African hypertension PHC scoping review. 2025. DOI 10.1080/17441692.2025.2579687. External evidence

